Gw&K Investment Management, LLC Global Blood Therapeutics, Inc. Transaction History

Gw&K Investment Management, LLC

$11.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$25.48 - $37.34 $2,548 - $3,734	-100 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$38.94 - $50.85 $1,635 - $2,135	-42 Reduced 29.58%	100 $4,000
Q4 2020 Feb 05, 2021	SELL	$37.65 - $63.77 $3.47 Million - $5.88 Million	-92,174 Reduced 99.85%	142 $6,000
Q3 2020 Nov 10, 2020	SELL	$52.76 - $74.49 $68,904 - $97,283	-1,306 Reduced 1.39%	92,316 $5.09 Million
Q2 2020 Aug 06, 2020	SELL	$48.73 - $81.82 $723,396 - $1.21 Million	-14,845 Reduced 13.69%	93,622 $5.91 Million
Q1 2020 May 11, 2020	SELL	$41.72 - $87.2 $41,678 - $87,112	-999 Reduced 0.91%	108,467 $5.54 Million
Q4 2019 Feb 10, 2020	SELL	$45.7 - $81.86 $1.6 Million - $2.87 Million	-35,048 Reduced 24.25%	109,466 $8.7 Million
Q3 2019 Nov 05, 2019	BUY	$45.35 - $57.91 $1.89 Million - $2.41 Million	41,642 Added 40.48%	144,514 $7.01 Million
Q2 2019 Aug 06, 2019	SELL	$52.6 - $63.29 $1.52 Million - $1.83 Million	-28,860 Reduced 21.91%	102,872 $5.41 Million
Q1 2019 May 14, 2019	SELL	$39.99 - $53.48 $842,749 - $1.13 Million	-21,074 Reduced 13.79%	131,732 $6.97 Million
Q4 2018 Feb 07, 2019	BUY	$31.54 - $46.67 $451,621 - $668,267	14,319 Added 10.34%	152,806 $6.27 Million
Q3 2018 Nov 06, 2018	SELL	$38.0 - $51.1 $31,350 - $42,157	-825 Reduced 0.59%	138,487 $5.26 Million
Q2 2018 Aug 07, 2018	BUY	$38.7 - $50.15 $793,466 - $1.03 Million	20,503 Added 17.26%	139,312 $6.3 Million
Q1 2018 May 08, 2018	SELL	$39.6 - $65.9 $1.07 Million - $1.77 Million	-26,908 Reduced 18.47%	118,809 $5.74 Million
Q4 2017 Jan 19, 2018	BUY	$29.7 - $45.7 $1.26 Million - $1.94 Million	42,519 Added 41.2%	145,717 $5.73 Million
Q3 2017 Oct 11, 2017	BUY	$25.1 - $31.05 $2.59 Million - $3.2 Million	103,198	103,198 $3.2 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Account